X

Trial Profile

Investigating the Association of Type of Anticoagulation Treatment for Non-valvular Atrial Fibrillation and Risk of Bleeding in England

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apixaban (Primary) ; Warfarin
Indications Stroke; Thromboembolism
Focus Therapeutic Use
Sponsors Bristol-Myers Squibb

Most Recent Events

28 Jun 2022 Status changed from active, no longer recruiting to withdrawn prior to enrolment.
29 Oct 2018 Planned End Date changed from 28 Dec 2018 to 29 May 2019.
29 Oct 2018 Planned primary completion date changed from 1 Oct 2018 to 4 Mar 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com